Insights Into Hodgkin Lymphoma (HL)
Perspectives of community physicians from across the US on the management of Hodgkin lymphoma (HL) with regard to clinical and nonclinical factors impacting treatment selection
Faculty Chair
Joseph Tuscano, MD
University of California Davis Health, Sacramento, CA, USA
Faculty Chair
Joanna Rhodes, MD
Northwell Health, New York, NY, USA
Faculty Chair
Barbara Pro, MD
Columbia University Irving Medical Center, New York, NY, USA
Faculty Chair
Vincent Herrin, MD
Merit Health Central, Jackson, MS, USA
Faculty Chair
Narendranath Epperla, MD
The Ohio State University Wexner Medical Center, Columbus, OH, USA
Faculty Chair
Krish Patel, MD
Center for Blood Disorders and Stem Cell Transplantation, Seattle, WA, USA
Faculty Chair
Radhakrishnan Ramchandren, MD
The University of Tennessee, Knoxville, TN, USA
Faculty Chair
Jeffrey Schriber, MD, FRCP
Cancer Treatment Centers of America, Phoenix, AZ, USA
Faculty Chair
John Burke, MD
Rocky Mountain Cancer Centers, Aurora, CO, USA
Faculty Chair
Andrew Whiteley, MD
Texas Oncology, Dallas, TX, USA
More Information
- Sacramento, CA
- California
More Information
- Philadelphia, PA
- Connecticut, Delaware, District of Columbia, Maine, Massachusetts, Maryland, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont
More Information
- Philadelphia, PA
- Mid-Atlantic Region
More Information
- Atlanta, GA
- Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee, Virginia, West Virginia
More Information
- Columbus, OH
- Illinois, Iowa, Nebraska, North Dakota, South Dakota, Wisconsin, Michigan, Indiana, Ohio
More Information
- Seattle, WA
- Northern California, Oregon, Washington, Idaho, Montana, Wyoming
More Information
- Nashville, TN
- Kansas, Oklahoma, Texas, Missouri, Arkansas, Louisiana
More Information
- Las Vegas, NV
- Southern California, Nevada, Utah, Arizona, New Mexico, Colorado
More Information
- Denver, CO
- Illinois, Iowa, Minnesota, Nebraska, North Dakota, South Dakota, Wisconsin, Michigan, Indiana, Ohio
More Information
- Dallas, TX
- Kansas, Oklahoma, Texas, Missouri, Arkansas, Louisiana
REPORT SNAPSHOT
- Assess advisors’ current management of cHL
- Gain insights into advisors’ perceptions of available therapies and understanding of data
- Understand the impact of pathways and other nonclinical factors that may affect treatment selection
GEOGRAPHIC REPRESENTATION AND CONTENT DEVELOPMENT
- Data collection was accomplished through use of audience response system questioning and moderated discussion
- The group of advisors comprised 10–15 medical oncologists
